Pharmafile Logo

Spanish reimbursement system

- PMLiVE

Novartis invests $1.3bn in protein degradation technology

Novartis will work with UK-based start-up Dunad Therapeutics to develop protein degradation drugs

- PMLiVE

How we’re empowering our teams to fight healthcare inequality

Welcoming Sheena Amin-Liebman as our new Diversity and Inclusion Director. Sheena will play a vital role in creating an inspiring environment that empowers staff to better guide its clients in...

Avalere Health

- PMLiVE

Men’s Health Awareness Month

In this November blog, Innovative Trials will be looking at the men's health and the Movember movement which aims at raising awareness around men's health

Innovative Trials

- PMLiVE

Merck’s $11.5bn acquisition of Acceleron delayed

Merck’s acquisition of Acceleron will take longer than expected as it refiles its paperwork, giving the FTC more time for review and itself more time to sell the deal to...

- PMLiVE

Novartis receives approval for third-generation leukaemia therapy

With a novel mechanism of action, Scemblix is a new option for people with chronic myeloid leukaemia who experience intolerance or inadequate response to standard therapy

- PMLiVE

Gilead sales rise by 13%, buoyed by anti-COVID-19 drug Veklury

The company has had a ‘very strong’ third quarter in spite of a sharp decline in its HIV portfolio due to generic competition

- PMLiVE

Sanofi sees double-digit growth driven by ‘megabrand’ Dupixent

With strong growth in specialty care, vaccines and consumer health seeing sales rise by 10% in the third quarter, Sanofi now expects earnings to grow by 14% in 2021

- PMLiVE

WHITE PAPER: Gender inequality—how COVID-19 impacted women

In this edition of MAGNIFI, we take a closer look into global gender inequality and how the pandemic has disproportionately impacted women. We ask—what can be done to level-up women...

IGNIFI

- PMLiVE

Clinical Researcher of the Year – The Americas 2021

The winners of the 2021 Clinical Researcher of the Year – The Americas competition have been announced during a live virtual awards ceremony

- PMLiVE

Government pledges £5bn for health R&D in the UK

The UK government has announced that it will spend £5bn on health-related R&D by 2025, a move welcomed by the pharmaceutical industry

- PMLiVE

Bespoke Gene Therapy Consortium created to collaborate in development of rare disease gene therapies

Ten pharma companies will team up with the FDA, NIH and five non-profits to accelerate the development of gene therapies to treat rare inherited diseases

Artificial Intelligence for Improving Patient Outcomes & Operational Efficiency

Jim Havelka, Founder & CEO of InformAI, discusses how AI can be used to improve medical diagnoses, patient treatment plans, outcome predictions, hospital risk mitigation, and operational efficiencies. He also...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links